Cost-utility analysis for advanced breast cancer therapy in Germany: results of the fulvestrant sequencing model.
- DOI
- 10.1007/s10549-008-0294-9
- Published
- 2009 Sep
- Container
- Breast cancer research and treatment
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s10549-008-0294-9,
title = {Cost-utility analysis for advanced breast cancer therapy in Germany: results of the fulvestrant sequencing model.},
author = {Lux MP and Hartmann M and Jackisch C and Raab G and Schneeweiss A and Possinger K and Oyee J and Harbeck N},
year = {2009},
journal = {Breast cancer research and treatment},
doi = {10.1007/s10549-008-0294-9},
url = {https://doi.org/10.1007/s10549-008-0294-9}
}RIS
TY - JOUR TI - Cost-utility analysis for advanced breast cancer therapy in Germany: results of the fulvestrant sequencing model. AU - Lux MP AU - Hartmann M AU - Jackisch C AU - Raab G AU - Schneeweiss A AU - Possinger K AU - Oyee J AU - Harbeck N PY - 2009 JO - Breast cancer research and treatment DO - 10.1007/s10549-008-0294-9 UR - https://doi.org/10.1007/s10549-008-0294-9 ER -
APA
MP, L., M, H., C, J., G, R., A, S., K, P., J, O., & N, H. (2009). Cost-utility analysis for advanced breast cancer therapy in Germany: results of the fulvestrant sequencing model.. Breast cancer research and treatment. https://doi.org/10.1007/s10549-008-0294-9
Source records
- pubmed · retrieved 2026-09-27T10:44:58.815Z